Relmada Therapeutics Stock Price History

RLMD Stock  USD 0.30  0  1.00%   
Below is the normalized historical share price chart for Relmada Therapeutics extending back to June 20, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Relmada Therapeutics stands at 0.30, as last reported on the 21st of March, with the highest price reaching 0.31 and the lowest price hitting 0.30 during the day.
IPO Date
9th of October 2014
200 Day MA
2.1921
50 Day MA
0.3288
Beta
0.646
 
Yuan Drop
 
Covid
If you're considering investing in Relmada Stock, it is important to understand the factors that can impact its price. Relmada Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0371, which implies the firm had a -0.0371 % return per unit of risk over the last 3 months. Relmada Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Relmada Therapeutics' Variance of 34.9, risk adjusted performance of (0.04), and Coefficient Of Variation of (1,740) to confirm the risk estimate we provide.
  
At present, Relmada Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 780.3 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 61 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 1,750. Relmada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0371

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRLMD

Estimated Market Risk

 5.87
  actual daily
52
52% of assets are less volatile

Expected Return

 -0.22
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Relmada Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Relmada Therapeutics by adding Relmada Therapeutics to a well-diversified portfolio.
Price Book
0.1917
Book Value
1.578
Enterprise Value
-45 M
Enterprise Value Ebitda
0.5431
Shares Float
27.6 M

Relmada Therapeutics Stock Price History Chart

There are several ways to analyze Relmada Stock price data. The simplest method is using a basic Relmada candlestick price chart, which shows Relmada Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 31, 20240.52
Lowest PriceFebruary 28, 20250.26

Relmada Therapeutics March 21, 2025 Stock Price Synopsis

Various analyses of Relmada Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Relmada Stock. It can be used to describe the percentage change in the price of Relmada Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Relmada Stock.
Relmada Therapeutics Price Rate Of Daily Change 1.01 
Relmada Therapeutics Accumulation Distribution 5,484 
Relmada Therapeutics Price Daily Balance Of Power 0.30 

Relmada Therapeutics March 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Relmada Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Relmada Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Relmada Stock and then apply it to test your longer-term investment strategies against Relmada.

Relmada Stock Price History Data

The price series of Relmada Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.26 with a coefficient of variation of 17.53. The price distribution for the period has arithmetic mean of 0.35. The median price for the last 90 days is 0.35. The company completed stock split (1:4) on 30th of September 2019. Relmada Therapeutics had dividends distributed to its stock-holders on 2019-09-30.
OpenHighLowCloseVolume
03/20/2025 0.30  0.31  0.30  0.30  169,999 
03/19/2025 0.30  0.31  0.28  0.30  216,489 
03/18/2025 0.29  0.30  0.29  0.30  146,973 
03/17/2025 0.29  0.30  0.28  0.29  282,078 
03/14/2025 0.28  0.30  0.27  0.29  1,050,181 
03/13/2025 0.26  0.28  0.26  0.27  285,195 
03/12/2025 0.27  0.28  0.26  0.27  201,765 
03/11/2025 0.28  0.29  0.27  0.27  278,946 
03/10/2025 0.28  0.29  0.27  0.27  341,975 
03/07/2025 0.27  0.29  0.26  0.29  524,631 
03/06/2025 0.26  0.27  0.25  0.27  440,091 
03/05/2025 0.26  0.27  0.26  0.26  275,174 
03/04/2025 0.25  0.26  0.24  0.26  488,673 
03/03/2025 0.26  0.26  0.24  0.26  447,424 
02/28/2025 0.27  0.28  0.26  0.26  342,756 
02/27/2025 0.27  0.28  0.26  0.28  384,808 
02/26/2025 0.28  0.29  0.26  0.27  254,873 
02/25/2025 0.28  0.29  0.26  0.28  323,660 
02/24/2025 0.29  0.29  0.28  0.29  414,223 
02/21/2025 0.31  0.32  0.29  0.30  774,628 
02/20/2025 0.33  0.33  0.31  0.31  606,271 
02/19/2025 0.32  0.34  0.31  0.33  444,141 
02/18/2025 0.35  0.35  0.32  0.33  705,433 
02/14/2025 0.32  0.36  0.31  0.33  1,278,618 
02/13/2025 0.30  0.35  0.29  0.33  1,280,526 
02/12/2025 0.29  0.31  0.28  0.30  710,691 
02/11/2025 0.30  0.30  0.28  0.29  958,237 
02/10/2025 0.30  0.31  0.29  0.31  1,252,277 
02/07/2025 0.32  0.34  0.29  0.31  2,945,339 
02/06/2025 0.48  0.49  0.33  0.34  26,026,020 
02/05/2025 0.33  0.39  0.32  0.38  1,125,734 
02/04/2025 0.33  0.34  0.32  0.34  197,381 
02/03/2025 0.34  0.35  0.31  0.34  541,500 
01/31/2025 0.35  0.37  0.34  0.35  342,326 
01/30/2025 0.37  0.37  0.34  0.35  464,396 
01/29/2025 0.36  0.38  0.35  0.36  646,328 
01/28/2025 0.36  0.37  0.35  0.36  212,178 
01/27/2025 0.38  0.39  0.34  0.37  444,265 
01/24/2025 0.37  0.40  0.37  0.39  312,635 
01/23/2025 0.39  0.39  0.38  0.38  135,348 
01/22/2025 0.39  0.39  0.36  0.39  642,350 
01/21/2025 0.37  0.38  0.36  0.37  272,595 
01/17/2025 0.40  0.40  0.36  0.37  208,625 
01/16/2025 0.38  0.41  0.36  0.38  609,000 
01/15/2025 0.40  0.41  0.39  0.40  264,599 
01/14/2025 0.40  0.44  0.39  0.40  420,087 
01/13/2025 0.42  0.44  0.38  0.40  532,366 
01/10/2025 0.45  0.45  0.40  0.41  559,536 
01/08/2025 0.46  0.48  0.44  0.45  744,103 
01/07/2025 0.44  0.49  0.43  0.47  881,517 
01/06/2025 0.47  0.48  0.44  0.44  1,292,504 
01/03/2025 0.44  0.48  0.43  0.47  942,258 
01/02/2025 0.52  0.52  0.45  0.45  1,865,095 
12/31/2024 0.48  0.53  0.42  0.52  2,467,012 
12/30/2024 0.39  0.49  0.39  0.46  3,339,476 
12/27/2024 0.36  0.41  0.36  0.38  1,246,990 
12/26/2024 0.36  0.37  0.35  0.36  338,736 
12/24/2024 0.36  0.37  0.34  0.36  609,998 
12/23/2024 0.39  0.40  0.35  0.38  542,264 
12/20/2024 0.34  0.38  0.34  0.36  425,048 
12/19/2024 0.35  0.37  0.34  0.35  673,407 

About Relmada Therapeutics Stock history

Relmada Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Relmada is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Relmada Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Relmada Therapeutics stock prices may prove useful in developing a viable investing in Relmada Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding34.6 M36.3 M
Net Loss-141.3 M-148.4 M

Relmada Therapeutics Quarterly Net Working Capital

47.62 Million

Relmada Therapeutics Stock Technical Analysis

Relmada Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Relmada Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Relmada Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run ETFs Now

   

ETFs

Find actively traded Exchange Traded Funds (ETF) from around the world
All  Next Launch Module

Relmada Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Relmada Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Relmada Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Relmada to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Relmada Stock analysis

When running Relmada Therapeutics' price analysis, check to measure Relmada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relmada Therapeutics is operating at the current time. Most of Relmada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relmada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relmada Therapeutics' price. Additionally, you may evaluate how the addition of Relmada Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance